BIO.WA Stock - Bioton S.a.
Unlock GoAI Insights for BIO.WA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $207.76M | $181.64M | $233.16M | $163.03M | $221.79M |
| Gross Profit | $64.84M | $72.85M | $95.75M | $76.32M | $104.70M |
| Gross Margin | 31.2% | 40.1% | 41.1% | 46.8% | 47.2% |
| Operating Income | $-5,709,000 | $15.29M | $21.26M | $14.34M | $48.58M |
| Net Income | $-15,658,000 | $2.27M | $1.42M | $2.88M | $33.92M |
| Net Margin | -7.5% | 1.3% | 0.6% | 1.8% | 15.3% |
| EPS | $-0.18 | $0.03 | $0.02 | $0.03 | $0.40 |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Visit WebsiteEarnings History & Surprises
BIO.WAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 30, 2025 | — | $0.05 | — | — |
Q2 2025 | Apr 29, 2025 | — | $-0.07 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.05 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.04 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.03 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.06 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.06 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.05 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.02 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.06 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.04 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.05 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.06 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.22 | — | — |
Q3 2020 | Sep 30, 2020 | — | $0.03 | — | — |
Latest News
Frequently Asked Questions about BIO.WA
What is BIO.WA's current stock price?
What is the analyst price target for BIO.WA?
What sector is Bioton S.a. in?
What is BIO.WA's market cap?
Does BIO.WA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BIO.WA for comparison